“GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS”, Mediterr J Hematol Infect Dis, vol. 3, no. 1, p. e2011019, May 2011, doi: 10.4084/mjhid.2011.019.